***OFFICIAL CYDY/Leronlimab Thread*** (2 Viewers)

[Golf Guy 69]

Please read this in the morning after you come back to reality and see if what you are saying makes any sense to yourself.

Its pure jibberish.  My guess is that you think you have strung together a cogent presentation but all you've managed to barely do is string a few unrelated sentences together.

After the safety results, she said they had topline study results and they probably weren't significant.  Was that assessment wrong?

 

[Dwayne Hoover]

After the safety results, she said they had topline study results and they probably weren't significant.  Was that assessment wrong?

This is what you are trying to say?  No, not wrong, I agreed with that.  It was obvious the primary endpoint hadn't been hit weeks ago or we would have heard something.

That being said, I do think that the data is solid on some secondary endpoints.

 

[chet]

After the safety results, she said they had topline study results and they probably weren't significant.  Was that assessment wrong?

I think it is wrong.  No disrespect to your daughter, but they did announce statistically significant results today.

 

[Golf Guy 69]

This is what you are trying to say?  No, not wrong, I agreed with that.  It was obvious the primary endpoint hadn't been hit weeks ago or we would have heard something.

Glad we all knew that, there was discussions saying it takes weeks.

 

[Golf Guy 69]

I think it is wrong.  No disrespect to your daughter, but they did announce statistically significant results today.

Topline?

 

[Dwayne Hoover]

Glad we all knew that, there was discussions saying it takes weeks.

Weeks to analyze all the data, sure. 

There was certainly a red flag that we didn't have something quicker for the primary endpoint though.  I don't think that's a shocking revelation to many here.  

 

[Golf Guy 69]

Topline results are basic, they accumulate every day.  

 

[chet]

Topline?

If by topline, you mean primary endpoint, then she was correct. However, they're looking for some/any statistically significant proof and they did get it.  I wasn't involved in the design of the trial, but I think that if the NEWS2 had been primary (like Polish Hammer) it would have been better for the stock.  I think the objective measure of NEWS2 is better than TSCC which is subjective to a certain extent.

At any rate,  Dr. Patterson confirmed that the today's data authenticated his MOA which was described in his manuscript.  I think that is important. 

 

[Golf Guy 69]

If by topline, you mean primary endpoint, then she was correct. However, they're looking for some/any statistically significant proof and they did get it.  I wasn't involved in the design of the trial, but I think that if the NEWS2 had been primary (like Polish Hammer) it would have been better for the stock.  I think the objective measure of NEWS2 is better than TSCC which is subjective to a certain extent.

At any rate,  Dr. Patterson confirmed that the today's data authenticated his MOA which was described in his manuscript.  I think that is important. 

Tell me what topline data is in drug research. Not what you think, clinically 

 

[Golf Guy 69]

Btw, topline data and primary are different.

 

[Golf Guy 69]

All this doesn't matter in the end.  We are long term so if we get stuck, it doesn't matter.  We need to short the shorts on the next short run.  

We drive the price low that they freak out and get undercut. No downside for us.

 

[adonis]

Btw, topline data and primary are different.

I know you’re not saying that in their top line report today they didn’t show anything significant, because obviously they did with NEWS2 coming in with p values under 5 at days 3 and 14.

so since that’s not what you’re saying, what are you saying?

 

[dkp993]

Honestly this is the first time in history that a stock has gone from $.30 to the $4/5 range in 7 months and people are pissing and moaning non-stop.  Tough crowd.  

 

[Golf Guy 69]

I know you’re not saying that in their top line report today they didn’t show anything significant, because obviously they did with NEWS2 coming in with p values under 5 at days 3 and 14.

so since that’s not what you’re saying, what are you saying?

topline is basic, blood pressure, breathing, pulse etc...stuff accumulated daily

 

[chet]

Honestly this is the first time in history that a stock has gone from $.30 to the $4/5 range in 7 months and people are pissing and moaning non-stop.  Tough crowd.  

 

[adonis]

Also, I still think too many folks don’t understand that missing the primary endpoint on a phase 2 trial but hitting on a significant secondary endpoint is majorly good for the company. 
 

the same cannot be said for missing on a phase 3 primary endpoint.  It seems that folks aren’t willing to accept that this is true, that the NEWS2 endpoint showing statistical significance is every bit as good, if not more, than hitting this specific primary endpoint for their phase 2 trial.

 

[Golf Guy 69]

Honestly this is the first time in history that a stock has gone from $.30 to the $4/5 range in 7 months and people are pissing and moaning non-stop.  Tough crowd.  

I made 300k and got more in the game.  I am looking best for all.  This is not personal (but kid).  

 

[SFBayDuck]

I’ll tell you in an hour when I speak Cav

Still weird that I’ve gotten all Cav with @Golf Guy 69, but you and I live in the same town and haven’t gotten Cav’d together yet. 
 

Back on topic, wtf are we doing with this now?  Is the run over, we won’t see $5.50+ again?  Can we still @BassNBrew (day trade) this in the $4-$5 range? Or are we going to slowly unwind back down to $1 while we wait for breast cancer and HIV results?

 

[adonis]

topline is basic, blood pressure, breathing, pulse etc...stuff accumulated daily

I’m not following where you’re headed.  The NEWS2 score is a leading indicator of who will likely become severe from this disease and leronlimab has statistically significant results showing on days 3 and 14 the patients are better off on the drug than off it.  
 

 

[Golf Guy 69]

Should I stop cause I made 300k on @chet back and still got 40+ shares?

 

[dkp993]

Hey my $2000 investment is sitting at a little over 11 grand right now even after today’s 2k drop.  You’ll get nothing but love from me my friend. 

 

[FreeBaGeL]

Even if/when the Covid stuff fails i think their stock still has a floor of around $1.  Cytodyn has a cult like following who won't give up no matter what.  They can always keep the clan believing by doing trials for one of the other 50'ish indications they claim.

Stop talking about us like we're not here.

 

[Golf Guy 69]

Still weird that I’ve gotten all Cav with @Golf Guy 69, but you and I live in the same town and haven’t gotten Cav’d together yet. 
 

Back on topic, wtf are we doing with this now?  Is the run over, we won’t see $5.50+ again?  Can we still @BassNBrew (day trade) this in the $4-$5 range? Or are we going to slowly unwind back down to $1 while we wait for breast cancer and HIV results?

wtf?  Where?

 

[Capella]

Still weird that I’ve gotten all Cav with @Golf Guy 69, but you and I live in the same town and haven’t gotten Cav’d together yet. 
 

Back on topic, wtf are we doing with this now?  Is the run over, we won’t see $5.50+ again?  Can we still @BassNBrew (day trade) this in the $4-$5 range? Or are we going to slowly unwind back down to $1 while we wait for breast cancer and HIV results?

I think (after today) the biggest news for this stock market whether it can get uplisted or not. The short manipulation of it on the OTC is just way too much to deal with, feels like it would be 2-3 dollars higher on nasdaq alone. 

 

[Golf Guy 69]

I made 300k and got more in the game.  I am looking best for all.  This is not personal (but kid).  

40k+ more shares.

 

[fruity pebbles]

I think (after today) the biggest news for this stock market whether it can get uplisted or not. The short manipulation of it on the OTC is just way too much to deal with, feels like it would be 2-3 dollars higher on nasdaq alone. 

I agree but isn’t the minimum bid price $4 on the Nasdaq to get listed? 

 

[dkp993]

I made 300k and got more in the game.  I am looking best for all.  This is not personal (but kid).  

Cool. I believe that. But I wasn’t referring to you specifically, just generally.  

 

[Golf Guy 69]

Still weird that I’ve gotten all Cav with @Golf Guy 69, but you and I live in the same town and haven’t gotten Cav’d together yet. 
 

Back on topic, wtf are we doing with this now?  Is the run over, we won’t see $5.50+ again?  Can we still @BassNBrew (day trade) this in the $4-$5 range? Or are we going to slowly unwind back down to $1 while we wait for breast cancer and HIV results?

I don't know, I see floor at 2 to 3.  I think day trading can give good results but thats bass not me.  I think the ceiling is limited right now but no one can tell me why it hit 10 before.

 

[CGRdrJoe]

Still weird that I’ve gotten all Cav with @Golf Guy 69, but you and I live in the same town and haven’t gotten Cav’d together yet. 
 

Back on topic, wtf are we doing with this now?  Is the run over, we won’t see $5.50+ again?  Can we still @BassNBrew (day trade) this in the $4-$5 range? Or are we going to slowly unwind back down to $1 while we wait for breast cancer and HIV results?

Yeah, we got to fix that 

 

[adonis]

Still weird that I’ve gotten all Cav with @Golf Guy 69, but you and I live in the same town and haven’t gotten Cav’d together yet. 
 

Back on topic, wtf are we doing with this now?  Is the run over, we won’t see $5.50+ again?  Can we still @BassNBrew (day trade) this in the $4-$5 range? Or are we going to slowly unwind back down to $1 while we wait for breast cancer and HIV results?

Not saying this as a loyalist, but the NEWS2 results are legitimately great results. Better than any current therapeutic currently in use for Covid.

why would we not hold?

 

[Capella]

I agree but isn’t the minimum bid price $4 on the Nasdaq to get listed? 

Read 3 or 4. Don’t really know. Would be bad if it dived under 3 for sure. 

 

[FreeBaGeL]

I've been pushing the importance of getting on the Naz for months now.  All along we've said that the science is will what matter in the end but that's only true if we're talking about holding for 3 years and the science means they've made enough in sales for the revenue/profit fundaments to make sense relative to a high market cap.

I think we've seen the last few weeks that most of us are not in it that long and we want to get the win and be done with it, and for that we need the PR and buying momentum which is both extremely attainable and even common in the markets right now, but that we will only get if this thing isn't trading OTC.  Down 10% on a day where they release the best COVID trial results of any drug to date prove that the science isn't going to make the momentum run if we're not listed.  On the Naz plus either good S/C PR or PR about m/m phase 3 starting up based on great phase 2 results for the new primary endpoint (NEWS2) are our best shots here.

 

[Golf Guy 69]

Not saying this as a loyalist, but the NEWS2 results are legitimately great results. Better than any current therapeutic currently in use for Covid.

why would we not hold?

Because if you are an up and comer in any space and do nothing a lot better than the ones there.......what is the chance on success?

I think the biggest thing ll had in keeping of the inflammation of organs.

 

[Zegras11]

I don't know, I see floor at 2 to 3.  I think day trading can give good results but thats bass not me.  I think the ceiling is limited right now but no one can tell me why it hit 10 before.

I could tell you, but I don't speak Cav

 

[Golf Guy 69]

I could tell you, but I don't speak Cav

Bull crap, you have known me long enough you are fluent.

 

[Zegras11]

Bull crap, you have known me long enough you are fluent.

Tried to sneak one buy you 

 

[Golf Guy 69]

Maybe we need focus on what CYDY says and mute the noise.

 

[Charlie Harper]

Because if you are an up and comer in any space and do nothing a lot better than the ones there.......what is the chance on success?

I think the biggest thing ll had in keeping of the inflammation of organs.

At the very least the M/M efficacy measured by NEWS2 and SAE decreases bodes well for S/C results. 

Not sure where the doom and gloom is coming from. 

 

[Otis]

Not saying this as a loyalist, but the NEWS2 results are legitimately great results. Better than any current therapeutic currently in use for Covid.

why would we not hold?

My link HTH

 

[Otis]

At the very least the M/M efficacy measured by NEWS2 and SAE decreases bodes well for S/C results. 

Not sure where the doom and gloom is coming from. 

My link HTH

 

[JerseyToughGuys]

Honestly this is the first time in history that a stock has gone from $.30 to the $4/5 range in 7 months and people are pissing and moaning non-stop.  Tough crowd.  

People FOMO’d in at the higher prices and are feeling the pain.

 

[adonis]

My link HTH

So we sell when the price goes down and buy when it goes up, and ignore the underlying strength, position or prospects of the company?

 

[Otis]

So we sell when the price goes down and buy when it goes up, and ignore the underlying strength, position or prospects of the company?

Link?

 

[adonis]

Link?

If you don't think those are true, why own the stock?

 

[Otis]

If you don't think those are true, why own the stock?

I don't know if they're true.  Everyone seems to be assuming it.  

And I was told there'd be riches.

 

[Capella]

I don't know if they're true.  Everyone seems to be assuming it.  

And I was told there'd be riches.

You’re exhausting. 
 

There’s a difference between the science being good and the share price rising. The CEO doesn’t know how to promote the product. We’ve been over the incompetence thousands of times, why do you keep saying the same thing. It’s like you’re stuck on repeat. 

 

[Dwayne Hoover]

If you look at twitter, you've got all the usual suspects on the short side calling it a failure vs the same on the CYDY side saying success.  

Its going to take some outside experts who like the results to move this stock positively. Until then, I do think the shorts will largely control this narrative.  There are enough speculators in this stock that are gonna bail.

SP up a little, hope Im wrong but not sure how long this holds until we get some outside confirmation.  I'm holding strong for now.

 

[Dwayne Hoover]

I don't know if they're true.  Everyone seems to be assuming it.  

And I was told there'd be riches.

You should definitely bail.  

 

[kevzilla]

Otis wants to get rich AND thin without doing any of the icky work that might be required. Which is his right, as unlikely as those outcomes might be.

 

[Charlie Harper]

Findings Between Feb 6, 2020, and March 12, 2020, 237 patients were enrolled and randomly assigned to a treatment 
group (158 to remdesivir and 79 to placebo); one patient in the placebo group who withdrew after randomisation was 
not included in the ITT population. Remdesivir use was not associated with a difference in time to clinical 
improvement (hazard ratio 1·23 [95% CI 0·87–1·75]). Although not statistically significant, patients receiving 
remdesivir had a numerically faster time to clinical improvement than those receiving placebo among patients with 
symptom duration of 10 days or less (hazard ratio 1·52 [0·95–2·43]). Adverse events were reported in 102 (66%) of 
155 remdesivir recipients versus 50 (64%) of 78 placebo recipients. Remdesivir was stopped early because of adverse 
events in 18 (12%) patients versus four (5%) patients who stopped placebo early.
Interpretation In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was not associated 
with statistically significant clinical benefits. However, the numerical reduction in time to clinical improvement in 
those treated earlier requires confirmation in larger studies.

These are the results from Remdesivir study. THIS IS THE CURRENT STANDARD OF CARE!!! Does anything in there sound better than LL?

CYDY has proven it decreases SAEs and actually has a statistically significant NEWS2 improvement. The drug works better than Remdesivir. It just needs press and traction. 

#notselling